ImmuPharma plc (AIM:IMM)
London
· Delayed Price · Currency is GBP · Price in GBX 2.520
+0.060 (2.44%)
Jun 11, 2025, 2:31 PM GMT+1
ImmuPharma Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
12.29M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |
ImmuPharma News
- 2 months ago - FX positioning info - Net speculative EUR longs surged in a sharp rise from previous week - Forexlive
- 3 months ago - Data show speculative traders have flipped from a net short to a net long position on euro - Forexlive
- 5 months ago - AIM Market Roundup: Immupharma, Poolbeg, Xeros - The Armchair Trader
- 9 months ago - Three Quick Facts: Norman Broadbent, Computacenter, Immupharma - The Armchair Trader